ערך בספרים למניה: Atrion (ATRI)

Atrion Corporation (ATRI) maintains its status as a technological leader in microsurgery and infusion systems. The calculated book value per share reflects asset dynamics, with the latest mark standing at 136.23. Current growth is driven by OEM component supplies, although new drivers are only beginning to emerge. The company's revenues rely on partnerships with cardiology and ophthalmology centers that value equipment reliability.

Book value per share determines the portion of net equity attributable to a single security, allowing for an assessment of the intrinsic value of assets minus liabilities. The trend in the calculated book value per share reflects the resilience of Atrion Corporation (ATRI) to rising raw material costs and logistical disruptions, which can reduce retained earnings and slow asset capitalization.